Research Paper Volume 16, Issue 1 pp 285—298
MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer
Figure 10. MAGE-A11 has the ability to regulate the proliferation of tumor cells. (A) The expression of MAGE-A11 was detected by QPCR in tumor cells and gastric epithelial cells. (B) CCK-8 assay was used to detect the effect of MAGE-A11 knockdown on cell viability. (C) EdU assay was used to detect the effect of MAGE-A11 knockdown on cell proliferation. (D) The expression of Ki67 was detected by cellular immunofluorescence.